Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of EGFR mutation status in cytology specimens: an institutional experience.

Diagnostic cytopathology - 1 Apr 2013

Aisner D L, Deshpande C, Baloch Z, Watt C D, Litzky L A, Malhotra B, Sepulveda A R, Langer C, Evans T, Van Deerlin V M

Abstract excerpt

Epidermal growth factor receptor (EGFR) mutation status has been shown to predict response to anti-EGFR tyrosine kinase inhibitors in non-small cell lung cancer (NSCLC). In patients with advanced-stage NSCLC, evaluation of mutational status is increasingly requested on biopsy or fine-needle aspiration specimens, which often have limited material. There are limited data on the suitability of cytology cell blocks...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Biopsy, Fine-Needle

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Non-Small-Cell Lung

Share to DNA Mutational Analysis

Share to DNA, Neoplasm

Share to ErbB Receptors

Share to Mutation Rate

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 22102479
DOI: 10.1002/dc.21851

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of EGFR mutation status in cytology specimens: an institutional experience.PMID 22102479Read ↗

EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer.Semantic proximity Read ↗

EGFR and KRAS mutations in lung carcinoma: molecular testing by using cytology specimens.Semantic proximity Read ↗

Molecular testing of cytology specimens: Issues in specimen adequacy and clinical utility.Semantic proximity Read ↗

EGFR gene mutation study in cytology specimens.Semantic proximity Read ↗

Comparison of Confirmed Cytology Smears and Cell Blocks for Epidermal Growth Factor Receptor Mutation Testing in Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Epidermal growth factor receptor mutation analysis in previously unanalyzed histology samples and cytology samples from the phase III Iressa Pan-ASia Study (IPASS).Semantic proximity Read ↗

Use of Exfoliative Specimens and Fine-Needle Aspiration Smears for Mutation Testing in Lung Adenocarcinoma.Semantic proximity Read ↗

EGFR mutation testing using archival-stained smears in non-small cell lung carcinoma.Semantic proximity Read ↗

Evaluation of 2-year experience with EGFR mutation analysis of small diagnostic samples.Semantic proximity Read ↗

Detection of epidermal growth factor receptor mutation in non-small-cell lung carcinoma using cytological and histological specimens.Semantic proximity Read ↗

EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples.Semantic proximity Read ↗

Assessment of epidermal growth factor receptor and K-ras mutation status in cytological stained smears of non-small cell lung cancer patients: correlation with clinical outcomes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.